Bladder cancer trials in China

In China 167 Also abroad 626

167 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Where
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou, Harbin, Jinan, Kunming, Lanzhou, Nanchang, Nanjing, Nanning, Ningbo, Qingdao, Shanghai, Shenyang, Suining Shi, Tianjin, Wenzhou, Wuhan, Xuzhou, Zhengzhou
Age
18 years and over
People
915 worldwide
Run by
AstraZeneca
See details and how to joinNCT07720284
Phase 3Taking people
DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC
Where
Shanghai
Age
18 years and over
People
182
Run by
Fudan University
See details and how to joinNCT07207824
Phase 2Taking people
Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration
Where
Shanghai
Age
18 years to 75 years
People
31
Run by
Changhai Hospital
See details and how to joinNCT07307456
Phase 2Taking people
Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer
Where
Guangzhou
Age
18 years and over
People
80
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07717242
Phase 3Taking people
A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC
Where
Beijing, Shanghai
Age
18 years and over
People
236
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07424287
Phase 2Taking people
Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)
Where
Tianjin
Age
18 years and over
People
21
Run by
Tianjin Medical University Second Hospital
See details and how to joinNCT05837806
Phase 2/3Taking people
Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
Where
Shanghai
Age
18 years to 80 years
People
840
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06879145
Phase 2Not yet taking people in China
PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer
Where
Nanjing
People
35
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07690878
No phaseTaking people
Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis
Where
Zhengzhou
Age
18 years and over
People
800
Run by
Henan Provincial People's Hospital
See details and how to joinNCT07614594
Phase 1Taking people
Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients
Where
Guangzhou
Age
18 years and over
People
12
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07119996
No phaseTaking people
Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC)
Where
Tianjin
Age
18 years and over
People
150
Run by
Tianjin Medical University Second Hospital
See details and how to joinNCT07321210
Phase 2Not yet taking people in China
Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)
Where
Shanghai
Age
18 years and over
People
75
Run by
Fudan University
See details and how to joinNCT07662863
Phase 2Taking people
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC
Where
Beijing
Age
18 years to 80 years
People
58
Run by
Peking University Third Hospital
See details and how to joinNCT07647289
Phase 2Not yet taking people in China
A Phase II Study of AK146D1 Mono or Combined With AK112 in Advanced Urothelial Carcinoma
Where
Shanghai
Age
18 years to 75 years
People
132
Run by
Akeso
See details and how to joinNCT07636772
Early phase 1Taking people
Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors
Where
Shanghai
Age
18 years and over
People
10
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07439120
No phaseTaking people
FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer
Where
Fuzhou
Age
18 years to 80 years
People
80
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT06421142
Phase 2/3Taking people
Trop2-targeted immunoPET Imaging of Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
400
Run by
RenJi Hospital
See details and how to joinNCT06851663
Phase 2Taking people
Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Where
Tianjin, Xingtai
Age
18 years and over
People
53
Run by
Tianjin Medical University Second Hospital
See details and how to joinNCT07475403
Phase 2Not yet taking people in China
HERO-UTUC: Intravesical RC48 After RNU for HER2+ UTUC
Where
Shanghai
Age
18 years to 85 years
People
49
Run by
RenJi Hospital
See details and how to joinNCT07591805
No phaseTaking people
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Where
Lanzhou
Age
18 years and over
People
150
Run by
Zhiping Wang
See details and how to joinNCT07589413
No phaseTaking people
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Where
Beijing
Age
18 years and over
People
200
Run by
Peking University First Hospital
See details and how to joinNCT07557225
Phase 2Not yet taking people in China
Biomarker-Enriched Kidney-Preserving Strategy With Disitamab Vedotin Plus Tislelizumab in HER2-Positive High-Risk Upper Tract Urothelial Carcinoma
Where
Shanghai
Age
18 years to 85 years
People
50
Run by
RenJi Hospital
See details and how to joinNCT07584733
Phase 2Taking people
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Where
Guangzhou, Kunming, Nanchang, Wuhan
Age
18 years and over
People
96
Run by
Sun Yat-sen University
See details and how to joinNCT07241793
No phaseNot yet taking people in China
An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models
Where
Nanning
Age
18 years to 60 years
People
1,080 worldwide
Run by
First Affiliated Hospital of Guangxi Medical University
See details and how to joinNCT07555756
No phaseNot yet taking people in China
Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma
Where
Beijing
Age
18 years and over
People
36
Run by
Peking University First Hospital
See details and how to joinNCT07504939